Articles

This article summarizes current biomarkers, available treatments, and future therapeutic approaches for Alzheimer's disease, discussing drug targets like Amyloid β, Tau Protein, and various other mechanisms. Additionally, it highlights the historical use of Estradiol, outcomes of trials with antioxidants and omega-3 fatty acids, and ongoing clinical trials, providing a comprehensive overview of the evolving landscape in AD research and treatment.

Recent research on Alzheimer's disease (AD) suggests that microglia, immune cells in the brain, may play a beneficial role in early disease stages but become harmful in later stages due to various spatial, temporal, and transcriptional factors. Understanding the phenotypic heterogeneity and multiple states of microglia could lead to advancements in personalized medicine and improved treatment outcomes for AD patients.

This Article supports SDG3 by evaluating sex and gender disparities in terms of risk factors, treatment uptake/completion, and virological outcomes for hepatitis C, finding differences between men and women in, for example, exposure to different risk factors and likelihood of commencing treatment. More attention is needed in research to these disparities and how they could be addressed

This article links to the United Nations Sustainable Development Goals (SDGs) by addressing Goal 3 (Good Health and Well-Being) and Goal 13 (Climate Action), as it highlights the significant greenhouse gas emissions associated with radiotherapy, a critical component of cancer treatment. By proposing strategies to reduce the environmental impact of oncology care through sustainable practices and treatment modifications, the study emphasizes the importance of integrating health care with climate action efforts to promote both patient well-being and environmental sustainability.